E-LIB Suche - Ergebnisse für: Noy, A.

1

LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBR..:

Soumerai, J. D. ; Dogan, A. ; Seshan, V....
Hematological Oncology. 41 (2023) S2 - p. 233-235 , 2023

Link: https://doi.org/10.1002/..

2

O168 A review of oral and oropharyngeal subsite classificat..:

Awad, L ; Langridge, B ; Sinha, D...
British Journal of Surgery. 110 (2023) Supplement_3 - p. , 2023

Link: https://doi.org/10.1093/..

3

DARATUMUMAB AND EPOCH FOR HIV+/‐ PLASMABLASTIC LYMPHOMA: A ..:

Noy, A. ; Barta, S. K. ; Tan, C. R....
Hematological Oncology. 41 (2023) S2 - p. 710-710 , 2023

Link: https://doi.org/10.1002/..

4

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DA..:

Torka, P. ; Feldman, T. ; Savage, K....
Hematological Oncology. 41 (2023) S2 - p. 161-162 , 2023

Link: https://doi.org/10.1002/..

5

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblas..:

Moskowitz, A. ; Savage, K. ; Feldman, T....
Hematological Oncology. 41 (2023) S2 - p. 351-353 , 2023

Link: https://doi.org/10.1002/..

6

Abstract No. 8 Predictors of adequacy and adverse events du..:

Kunin, H. ; Wijetunga, N. ; Erinjeri, J...
Journal of Vascular and Interventional Radiology. 33 (2022) 6 - p. S5-S6 , 2022

Link: https://doi.org/10.1016/..

7

KEY GENETIC AND MOLECULAR ABERRATIONS IDENTIFIED IN BOTH AD..:

Orem, J. ; Martin, M.‐R. ; Mbulaiteye, S. M....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

BENDAMUSTINE, RITUXIMAB, AND POLATUZUMAB VEDOTIN FOR RELAPS..:

Farina, K. A ; Drill, E ; Buie, L. W...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ..:

Horwitz, S. M. ; Moskowitz, A. J. ; Mehta‐Shah, N....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglo..:

Kumar, Anita ; Bantilan, K.S. ; Jacob, A.P....
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) 4 - p. 230-237.e12 , 2021

Link: https://doi.org/10.1016/..

11

PRELIMINARY ACTIVITY OF DEVIMISTAT (CPI 613) IN PATIENTS WI..:

Nikolaenko, L. ; Pardee, T. S. ; Steiner, R....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

12

CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAG..:

Sha, F. ; Okwali, M. ; Alperovich, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

13

COPY NUMBER VARIATION ANALYSIS IDENTIFIES DISTINCT GENOMIC ..:

Dreval, K. ; Thomas, N. ; Gerhard, D. S....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

14

P14.21 Tehila Kaisman-Elbaz MD/PhD:

Kaisman-Elbaz, T ; Elbaz, Y ; Merkin, V...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii71-iii71 , 2019

Link: https://doi.org/10.1093/..

15

CLINICAL CHARACTERISTICS AND OUTCOMES OF STAGE I DIFFUSE LA..:

Bobillo, S. ; Joffe, E. ; Lavery, J....
Hematological Oncology. 37 (2019) S2 - p. 251-252 , 2019

Link: https://doi.org/10.1002/..